All Resources

Our resource hub to discover reports, policy papers and other forms of informative content

Filter by

Letter to The Honourable Mary Ng, P.C., M.P.

IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.

*Cette lettre est disponible en anglais seulement.

Learn more | View

Letter to the Honourable Patty Hajdu

IMC requests that the Honourable Patty Hadju suspend the July 1, 2021 implementation of regulatory changes to the PMPRB until the COVID-19 pandemic has abated.

Learn more | View

IMC Response to PMPRB Draft Guidelines

IMC responds to PMPRB draft guidelines released November 21, 2019, stating a balance must be struck between budgetary pressures confronting Canadian governments and the preservation of Canadians’ timely access to life-saving innovative medicines.

Learn more | View


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.